{"id":1066,"date":"2018-02-09T11:13:17","date_gmt":"2018-02-09T11:13:17","guid":{"rendered":"https:\/\/newsite.osmr.ro\/?p=1066"},"modified":"2021-05-31T15:13:07","modified_gmt":"2021-05-31T15:13:07","slug":"siguranta-pacientului-prin-siguranta-medicamentului-1-an-pana-la-operationalizarea-sistemului-national-de-verificare-a-medicamentelor","status":"publish","type":"post","link":"https:\/\/osmr.ro\/en\/siguranta-pacientului-prin-siguranta-medicamentului-1-an-pana-la-operationalizarea-sistemului-national-de-verificare-a-medicamentelor\/","title":{"rendered":"Patient Safety through Medicines Safety &#8211; 1 year until the Go-Live of the National Medicines Verification System"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"--awb-bg-size:cover;--awb-margin-bottom:0px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-1\"><p>Rom\u00e2nia a intrat \u00een linie dreapt\u0103 \u00een procesul de implementare a Sistemului European de Verificare a Medicamentelor<\/p>\n<p>09.02.2018 Bucure\u0219ti \u2013 \u201eAst\u0103zi a fost demarat oficial \u0219i \u00een Rom\u00e2nia procesul de implementare a Sistemului European de Verificare a Medicamentelor, sistem care va deveni opera\u021bional \u00een toate \u021b\u0103rile UE \u00eencep\u00e2nd cu 9 februarie 2019. De la aceast\u0103 dat\u0103, doar medicamentele care respect\u0103 noile reguli de securitate vor putea fi puse \u00een circula\u021bie pe teritoriul Uniunii Europene. Serializarea medicamentelor este o ini\u021biativ\u0103 esen\u021bial\u0103 pentru siguran\u021ba \u0219i s\u0103n\u0103tatea pacien\u021bilor, \u00een condi\u021biile \u00een care pericolul intr\u0103rii medicamentelor falsificate \u00een lan\u021bul comercial este tot mai mare. Aceasta este prima directiv\u0103 european\u0103 a c\u0103rei implementare \u0219i finan\u021bare intr\u0103 100% \u00een sarcina sectorului privat, respectiv a industriei farmaceutice\u201d, a declarat Dan ZAHARESCU, Pre\u0219edintele Organiza\u021biei de Serializare a Medicamentelor din Rom\u00e2nia (OSMR) \u0219i Director Executiv al ARPIM, \u00een cadrul Conferin\u021bei Na\u021bionale Siguran\u021ba Pacientului prin Siguran\u021ba Medicamentului \u2013 1 an p\u00e2n\u0103 la opera\u021bionalizarea Sistemului Na\u021bional de Verificare a Medicamentelor.<\/p>\n<p>Evenimentul a marcat lansarea oficial\u0103 a procesului de implementare a sistemului \u00een Rom\u00e2nia \u0219i a confirmat angajamentul ferm al tuturor p\u0103r\u021bilor angrenate \u00een implementarea noii legisla\u021bii, de la reprezentan\u021bii industriei farmaceutice, p\u00e2n\u0103 la autorit\u0103\u021bile direct implicate, precum Ministerul S\u0103n\u0103t\u0103\u021bii \u015fi Agen\u021bia Na\u021bional\u0103 a Medicamentului \u0219i a Dispozitivelor Medicale. Autorit\u0103\u0163ile prezente \u0219i-au asumat s\u0103 asigure finalizarea proiectului na\u021bional la termenul stabilit \u0219i s\u0103 ofere tot sprijinul OSMR \u00een vederea implement\u0103rii sistemului \u00een cele mai bune condi\u021bii.<\/p>\n<p>Doamna dr. Diana Loreta P\u0102UN, Consilier de Stat \u00een Departamentul de S\u0103n\u0103tate Public\u0103 din cadrul Administra\u021biei Preziden\u021biale \u0219i doamna Melania Gabriela CIOT, Secretar de Stat \u00een cadrul Ministerului Afacerilor Externe au subliniat faptul c\u0103 procesul de implementare al Sistemului Na\u021bional de Verificare a Medicamentelor este cu at\u00e2t mai important, \u00een contextul \u00een care Rom\u00e2nia va de\u021bine \u00een anul 2019 pre\u015fedin\u021bia Consiliului UE, ceea ce implic\u0103 o \u0219i mai mare responsabilitate pentru \u021bara noastr\u0103, care dep\u0103\u0219e\u0219te spa\u021biul local \u0219i se extinde la nivel european.<\/p>\n<p>Dr. Florin BUICU, Pre\u0219edintele Comisiei pentru s\u0103n\u0103tate \u0219i familie din Camera Deputa\u021bilor a atras aten\u021bia asupra faptului c\u0103 avem \u00een fa\u021b\u0103 un an extrem de plin, c\u0103 sunt foarte multe lucruri de f\u0103cut \u00eentr-un timp scurt \u0219i de aceea este important ca dezbaterea de ast\u0103zi s\u0103 genereze un plan din care s\u0103 reias\u0103 foarte clar pa\u0219ii pe care \u00eei avem de f\u0103cut mai departe.<\/p>\n<p>Stadiul actual al implement\u0103rii la nivelul\u00a0 Uniunii Europene \u0219i eforturile de coordonare \u0219i supervizare din partea autorit\u0103\u021bilor au fost prezentate de Excelen\u021ba Sa domnul Cristian BUCHIU, \u0218ef-adjunct al Reprezentan\u021bei Comisiei Europene la Bucure\u0219ti, iar prezentarea detaliilor tehnice referitoare la implementarea \u00een plan European a fost facut\u0103 \u00a0de domnul Andreas WALTER, Director General al EMVO \u2013 European Medicines Verification Organisation \u0219i de doamna Ulrike KREYSA, Prim-Vicepre\u0219edinte Healthcare al GS1 Global, organiza\u021bia global\u0103 de standardizare ce faciliteaz\u0103 implementarea \u00een materie de identificatori unici globali \u0219i simbologie cod de bar\u0103 bidimensional, Data Matrix ECC 200.<\/p>\n<p>\u201eDe\u021bin\u0103torii autoriza\u021biei de punere pe pia\u021b\u0103 \u0219i produc\u0103torii sunt obliga\u021bi s\u0103 produc\u0103 medicamentele vizate de noua legisla\u021bie cu dou\u0103 elemente de siguran\u021b\u0103 ce se verific\u0103 obligatoriu \u00eenainte de a fi eliberate c\u0103tre pacient: un identificator unic ce permite autentificarea ambalajului individual pe care acesta este imprimat \u0219i un dispozitiv de protec\u021bie \u00eempotriva modific\u0103rilor ilicite, ce permite verificarea integrit\u0103\u021bii fizice a ambalajului \u0219i poate eviden\u0163ia orice tentativ\u0103 de modificare ilicit\u0103 a acestuia\u201d, a explicat Alexandru CHETRU\u0218C\u0102, Project Manager Arvato, compania care va fi responsabil\u0103 cu implementarea modulului na\u021bional \u00een Rom\u00e2nia, modul care va fi parte integrant\u0103 din Sistemul European de Verificare a Medicamentelor.<\/p>\n<p>\u201eImplementarea sistemului na\u021bional de verificare a medicamentelor presupune parcurgerea urm\u0103torilor pa\u0219i, care sunt obligatorii: clarificarea reglement\u0103rilor na\u021bionale necesare produc\u0103torilor\u00a0 pentru a demara trecerea la noile ambalaje \u0219i pentru a asigura cu succes perioada de tranzi\u021bie \u00een pia\u021b\u0103 la noile reguli, introducerea prin intermediul Hub-ului european \u00een modulul na\u021bional a datelor despre medicamentele ce vor fi eliberate pacien\u021bilor rom\u00e2ni \u0219i clarificarea regulilor na\u021bionale necesare organiza\u021biilor implicate \u00een distribu\u021bia \u0219i eliberarea medicamentelor c\u0103tre pacien\u021bi, pentru a cunoa\u0219te cine, c\u00e2nd \u0219i cum trebuie s\u0103 realizeze verific\u0103rile \u00een sistem \u0219i inspec\u021biile fizice ale ambalajelor \u201d, a continuat Alexandru CHETRU\u0218C\u0102.<\/p>\n<h2>Siguranta Pacientului prin Siguranta Medicamentului<\/h2>\n<p><a href=\"https:\/\/osmr.ro\/wp-content\/uploads\/2018\/02\/reg_2016_161_ro.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Regulamentul Delegat UE nr. 2016\/161<\/a> stipuleaz\u0103 obligativitatea introducerii elementelor de siguran\u021b\u0103 pe medicamentele cu prescrip\u021bie \u0219i pe anumite medicamente f\u0103r\u0103 prescrip\u021bie, men\u021bionate de legisla\u021bie \u0219i \u00een acest mod se garanteaz\u0103 autenticitatea medicamentelor \u0219i se previne intrarea medicamentelor falsificate \u00een lan\u021bul legal european de comercializare.<\/p>\n<p>Conform regulamentului UE, fiecare \u021bar\u0103 european\u0103 trebuie s\u0103 pun\u0103 la punct un Sistem Na\u021bional de Verificare a Medicamentelor, ce va fi implementat \u0219i administrat de c\u0103tre o organiza\u021bie na\u021bional\u0103 a industriei farmaceutice. Scopul acestui Sistem este s\u0103 func\u021bioneze ca o platform\u0103 unde to\u021bi actorii interesa\u021bi, de la produc\u0103tori, la distribuitori, la farmacii sau spitale, s\u0103 poat\u0103 verifica autenticitatea medicamentelor, prin verificarea identificatorului unic al fiec\u0103rui produs. Sistemul na\u021bional va fi conectat la un sistem european, EU-Hub, ce va integra \u0219i centraliza datele \u0219i informa\u021biile de la nivelul Uniunii Europene. \u00cen Rom\u00e2nia, implementarea sistemului de serializare este coordonat\u0103 de c\u0103tre Organiza\u021bia de Serializare a Medicamentelor.<\/p>\n<p>Evenimentul Siguran\u021ba Pacientului prin Siguran\u021ba Medicamentului \u2013 1 an p\u00e2n\u0103 la opera\u021bionalizarea Sistemului Na\u021bional de Verificare a Medicamentelor a reunit peste 200 de participan\u021bi din \u00eentregul sistem de s\u0103n\u0103tate, precum autorit\u0103\u021bi, asocia\u021bii profesionale, produc\u0103tori, importatori \u0219i distribuitori de medicamente, farmacii publice \u0219i de spital, reprezentan\u021bi ai companiilor produc\u0103toare de software dedicat industriei farmaceutice, asocia\u021bii de pacien\u021bi \u0219i reprezentan\u021bi ai mass media.<\/p>\n<p><strong><a href=\"https:\/\/osmr.ro\/wp-content\/uploads\/2018\/02\/PrezentariEveniment.zip\">Download Prezent\u0103ri Eveniment<\/a><\/strong><\/p>\n<\/div><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-center fusion-title-text fusion-title-size-three\" style=\"--awb-margin-top-small:40px;--awb-margin-right-small:0px;--awb-margin-bottom-small:20px;--awb-margin-left-small:0px;\"><h3 class=\"fusion-title-heading title-heading-center fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:32;line-height:1.3;\">Dan Zaharescu \u2013 Pre\u0219edinte <a href=\"https:\/\/osmr.ro\">OSMR<\/a><\/h3><\/div><div class=\"fusion-video fusion-youtube fusion-aligncenter\" style=\"--awb-max-width:800px;--awb-max-height:450px;--awb-width:100%;\"><div class=\"video-shortcode\"><div class=\"fluid-width-video-wrapper\" style=\"padding-top:56.25%;\" ><iframe class=\"lazyload\" title=\"YouTube video player 1\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27800%27%20height%3D%27450%27%20viewBox%3D%270%200%20800%20450%27%3E%3Crect%20width%3D%27800%27%20height%3D%27450%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.youtube.com\/embed\/nlZL3vJXqOg?wmode=transparent&autoplay=0\" width=\"800\" height=\"450\" allowfullscreen allow=\"autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture;\"><\/iframe><\/div><\/div><\/div><div class=\"fusion-text fusion-text-2\"><p>\u201eDe\u0219i, \u00een epoca \u00een care tr\u0103im, un asemenea proces de verificare ar putea s\u0103 par\u0103 banal, el reprezint\u0103 o provocare la nivelul industriei farmaceutice, necesit\u00e2nd coordonarea tuturor actorilor de pe pia\u021ba farmaceutic\u0103 european\u0103, \u00eentr-un efort concertat, pentru crearea unui Sistem European de Verificare a Medicamentelor care, apoi, este replicat la nivelul fiec\u0103rui Stat Membru \u0219i cu care interac\u021bioneaz\u0103 continu\u0103.\u201d<\/p>\n<\/div><div class=\"fusion-title title fusion-title-2 fusion-sep-none fusion-title-center fusion-title-text fusion-title-size-three\" style=\"--awb-margin-top-small:40px;--awb-margin-right-small:0px;--awb-margin-bottom-small:20px;--awb-margin-left-small:0px;\"><h3 class=\"fusion-title-heading title-heading-center fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:32;line-height:1.3;\">Dr. Diana Loreta P\u0103un \u2013\u00a0Consilier de Stat \u2013 Departamentul de S\u0103n\u0103tate Public\u0103 \u2013\u00a0 Administra\u021bia Preziden\u021bial\u0103<\/h3><\/div><div class=\"fusion-video fusion-youtube fusion-aligncenter\" style=\"--awb-max-width:800px;--awb-max-height:450px;--awb-width:100%;\"><div class=\"video-shortcode\"><div class=\"fluid-width-video-wrapper\" style=\"padding-top:56.25%;\" ><iframe class=\"lazyload\" title=\"YouTube video player 2\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27800%27%20height%3D%27450%27%20viewBox%3D%270%200%20800%20450%27%3E%3Crect%20width%3D%27800%27%20height%3D%27450%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.youtube.com\/embed\/4NV1KieRqLM?wmode=transparent&autoplay=0\" width=\"800\" height=\"450\" allowfullscreen allow=\"autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture;\"><\/iframe><\/div><\/div><\/div><div class=\"fusion-text fusion-text-3\"><p>\u201d Vorbim despre pia\u021ba medicamentelor, despre un lan\u021b de aprovizionare care dep\u0103\u0219e\u0219te grani\u021bele fizice ale statelor, astfel c\u0103 solu\u021bia nu poate fi dec\u00e2t cea de cooperare \u00een acest domeniu, de armonizare \u0219i de utilizare a acelora\u0219i elemente de siguran\u021b\u0103, folosite de c\u0103tre toate Statele Membre, pentru prevenirea p\u0103trunderii medicamentelor falsificate \u00een lan\u021bul de aprovizionare, \u00een esen\u021b\u0103, despre ceea ce \u00eenseamn\u0103 Sistemul European de Verificare a Medicamentelor\u201d<\/p>\n<\/div><div class=\"fusion-title title fusion-title-3 fusion-sep-none fusion-title-center fusion-title-text fusion-title-size-three\" style=\"--awb-margin-top-small:40px;--awb-margin-right-small:0px;--awb-margin-bottom-small:20px;--awb-margin-left-small:0px;\"><h3 class=\"fusion-title-heading title-heading-center fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:32;line-height:1.3;\">Melania Gabriel Ciot \u2013 Secretar de Stat \u2013 <a href=\"https:\/\/www.mae.ro\/\" target=\"_blank\" rel=\"noopener\">Ministerul Afacerilor Externe<\/a><\/h3><\/div><div class=\"fusion-video fusion-youtube fusion-aligncenter\" style=\"--awb-max-width:800px;--awb-max-height:450px;--awb-width:100%;\"><div class=\"video-shortcode\"><div class=\"fluid-width-video-wrapper\" style=\"padding-top:56.25%;\" ><iframe class=\"lazyload\" title=\"YouTube video player 3\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27800%27%20height%3D%27450%27%20viewBox%3D%270%200%20800%20450%27%3E%3Crect%20width%3D%27800%27%20height%3D%27450%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.youtube.com\/embed\/yDNWZsK0bRg?wmode=transparent&autoplay=0\" width=\"800\" height=\"450\" allowfullscreen allow=\"autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture;\"><\/iframe><\/div><\/div><\/div><div class=\"fusion-text fusion-text-4\"><p>\u201d Subiectul este unul cu relevan\u021b\u0103 multipl\u0103, av\u00e2nd \u00een vedere, pe de-o parte, necesitatea asigur\u0103rii unui tratament adecvat al pacien\u021bilor, iar, pe de alt\u0103 parte, beneficiile pe care opera\u021bionalizarea unui Sistem European de Verificare a Medicamentelor le va genera pentru to\u021bi cet\u0103\u021benii europeni. Politica european\u0103 \u00een domeniul s\u0103n\u0103ta\u021bii este o tematic\u0103 pe care o avem \u00een vedere cu prioritate \u0219i din calitatea de viitoare Pre\u0219edin\u021bie a Consiliului Uniunii Europene \u00een semestrul 1 al anului 2019\u2033<\/p>\n<\/div><div class=\"fusion-title title fusion-title-4 fusion-sep-none fusion-title-center fusion-title-text fusion-title-size-three\" style=\"--awb-margin-top-small:40px;--awb-margin-right-small:0px;--awb-margin-bottom-small:20px;--awb-margin-left-small:0px;\"><h3 class=\"fusion-title-heading title-heading-center fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:32;line-height:1.3;\">Dr. Florin Buicu \u2013 Pre\u0219edintele <a href=\"http:\/\/www.cdep.ro\/pls\/parlam\/structura2015.co?idc=8\" target=\"_blank\" rel=\"noopener\">Comisiei de S\u0103n\u0103tate din Camera Deputatilor<\/a><\/h3><\/div><div class=\"fusion-video fusion-youtube fusion-aligncenter\" style=\"--awb-max-width:800px;--awb-max-height:450px;--awb-width:100%;\"><div class=\"video-shortcode\"><div class=\"fluid-width-video-wrapper\" style=\"padding-top:56.25%;\" ><iframe class=\"lazyload\" title=\"YouTube video player 4\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27800%27%20height%3D%27450%27%20viewBox%3D%270%200%20800%20450%27%3E%3Crect%20width%3D%27800%27%20height%3D%27450%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.youtube.com\/embed\/14nhUEkzvTw?wmode=transparent&autoplay=0\" width=\"800\" height=\"450\" allowfullscreen allow=\"autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture;\"><\/iframe><\/div><\/div><\/div><div class=\"fusion-text fusion-text-5\"><p>\u201eUn an pare destul de mult, dar nu e mult deloc. Merg\u00e2nd pe lan\u021b, \u00eenapoi de la pacient, avem nevoie \u0219i de siguran\u021ba medicamentului. Aceast\u0103 serializare, aceast\u0103 aplicare a codului unic pentru fiecare cutie de medicamente este, de fapt, un instrument. V\u0103 asigur de toat\u0103 deschiderea necesar\u0103 din partea Comisiei de S\u0103n\u0103tate a Camerei Deputa\u021bilor, dar \u0219i din partea Comisiei de S\u0103n\u0103tate Public\u0103 a Senatului, prin persoana dlui Pre\u0219edinte L\u00c1SZL\u00d3 Attila care v\u0103 transmite, \u0219i d\u00e2nsul, salutul domniei-sale.\u201d<\/p>\n<\/div><div class=\"fusion-title title fusion-title-5 fusion-sep-none fusion-title-center fusion-title-text fusion-title-size-three\" style=\"--awb-margin-top-small:40px;--awb-margin-right-small:0px;--awb-margin-bottom-small:20px;--awb-margin-left-small:0px;\"><h3 class=\"fusion-title-heading title-heading-center fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:32;line-height:1.3;\">Dr. Alexandru Velicu \u2013 Pre\u0219edinte <a href=\"https:\/\/www.anm.ro\/\" target=\"_blank\" rel=\"noopener\">ANMDM<\/a><\/h3><\/div><div class=\"fusion-video fusion-youtube fusion-aligncenter\" style=\"--awb-max-width:800px;--awb-max-height:450px;--awb-width:100%;\"><div class=\"video-shortcode\"><div class=\"fluid-width-video-wrapper\" style=\"padding-top:56.25%;\" ><iframe class=\"lazyload\" title=\"YouTube video player 5\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27800%27%20height%3D%27450%27%20viewBox%3D%270%200%20800%20450%27%3E%3Crect%20width%3D%27800%27%20height%3D%27450%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.youtube.com\/embed\/-_4peOh2hLI?wmode=transparent&autoplay=0\" width=\"800\" height=\"450\" allowfullscreen allow=\"autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture;\"><\/iframe><\/div><\/div><\/div><div class=\"fusion-text fusion-text-6\"><p>\u201ePotrivit dispozi\u021biilor \u00een vigoare, institu\u021bia noastr\u0103 va adopta \u0219i aplica normele detaliate pentru elementele de siguran\u021b\u0103. ANMDM se angajeaz\u0103 s\u0103 participe activ la Grupurile de Lucru stabilite de c\u0103tre Consiliul Director al OSMR, \u00een care reprezentan\u021bii Agen\u021biei vor colabora str\u00e2ns cu reprezentan\u021bii Ministerului S\u0103n\u0103ta\u021bii, CNAS, cu reprezentan\u021bii DAPP, cu reprezentan\u021bii farmaciilor publice \u0219i private, cu reprezentan\u021bi ai distribuitorilor \u0219i importatorilor de medicamente.\u201d<\/p>\n<\/div><div class=\"fusion-title title fusion-title-6 fusion-sep-none fusion-title-center fusion-title-text fusion-title-size-three\" style=\"--awb-margin-top-small:40px;--awb-margin-right-small:0px;--awb-margin-bottom-small:20px;--awb-margin-left-small:0px;\"><h3 class=\"fusion-title-heading title-heading-center fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:32;line-height:1.3;\">Lidia Onofrei -Director \u2013 Directia politica medicamentului si a dispozitivelor medicale Ministerul S\u0103n\u0103t\u0103\u021bii<\/h3><\/div><div class=\"fusion-video fusion-youtube fusion-aligncenter\" style=\"--awb-max-width:800px;--awb-max-height:450px;--awb-width:100%;\"><div class=\"video-shortcode\"><div class=\"fluid-width-video-wrapper\" style=\"padding-top:56.25%;\" ><iframe class=\"lazyload\" title=\"YouTube video player 6\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27800%27%20height%3D%27450%27%20viewBox%3D%270%200%20800%20450%27%3E%3Crect%20width%3D%27800%27%20height%3D%27450%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.youtube.com\/embed\/w_XfE76Q7xs?wmode=transparent&autoplay=0\" width=\"800\" height=\"450\" allowfullscreen allow=\"autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture;\"><\/iframe><\/div><\/div><\/div><div class=\"fusion-text fusion-text-7\"><p>\u201eDat\u0103 fiind importan\u021ba implement\u0103rii cu succes a acestui sistem, de care depinde siguran\u021ba pacien\u021bilor, autorit\u0103\u021bile na\u021bionale vor sprijini OSMR \u00een demersurile sale de implementare a Directivei.\u201d<\/p>\n<\/div><div class=\"fusion-title title fusion-title-7 fusion-sep-none fusion-title-center fusion-title-text fusion-title-size-three\" style=\"--awb-margin-top-small:40px;--awb-margin-right-small:0px;--awb-margin-bottom-small:20px;--awb-margin-left-small:0px;\"><h3 class=\"fusion-title-heading title-heading-center fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:32;line-height:1.3;\">Andreas Walter \u2013 Director General \u2013 <a href=\"https:\/\/emvo-medicines.eu\/\" target=\"_blank\" rel=\"noopener\">EMVO<\/a> \u2013 Director General al European Medicines Verification Organization (EMVO) din aprilie 2016<\/h3><\/div><div class=\"fusion-text fusion-text-8\"><p>Andreas Walter a fost Director de Proiect \u00een cadrul Falsified Medicines Directive (FMD) din cadrul European Federation of Pharmaceutical Industries and Associations (EFPIA) \u0219i director interimar al EMVO \u00eenc\u0103 din anul 2015.<br \/>\nEMVO este o organiza\u021bie cu sediul la Bruxelles, creat\u0103 de industrie, pe baza prevederilor Directiva privind Medicamentele Falsificate (FMD) \u0219i Regulamentului Delegat (RD), pentru dezvoltarea \u0219i implementarea Sistemului European de Verificare a Medicamentelor (EMVS).<\/p>\n<\/div><div class=\"fusion-video fusion-youtube fusion-aligncenter\" style=\"--awb-max-width:800px;--awb-max-height:450px;--awb-width:100%;\"><div class=\"video-shortcode\"><div class=\"fluid-width-video-wrapper\" style=\"padding-top:56.25%;\" ><iframe class=\"lazyload\" title=\"YouTube video player 7\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27800%27%20height%3D%27450%27%20viewBox%3D%270%200%20800%20450%27%3E%3Crect%20width%3D%27800%27%20height%3D%27450%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.youtube.com\/embed\/hdZWuY69Vg8?wmode=transparent&autoplay=0\" width=\"800\" height=\"450\" allowfullscreen allow=\"autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture;\"><\/iframe><\/div><\/div><\/div><div class=\"fusion-text fusion-text-9\"><p>\u201eTrebuie s\u0103 conect\u0103m 32 de \u021b\u0103ri, 100 000 de distribuitori; 10,5 miliarde de cutii\/an ce trebuie serializate; este o mare provocare pentru to\u021bi stakeholderii, dar \u0219i pentru Autorit\u0103\u021bile Na\u021bionale Competente, deoarece acestea au nu numai rol de supervizare, dar ele sunt \u0219i stakeholder.\u201d<\/p>\n<\/div><div class=\"fusion-title title fusion-title-8 fusion-sep-none fusion-title-center fusion-title-text fusion-title-size-three\" style=\"--awb-margin-top-small:40px;--awb-margin-right-small:0px;--awb-margin-bottom-small:20px;--awb-margin-left-small:0px;\"><h3 class=\"fusion-title-heading title-heading-center fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:32;line-height:1.3;\">Cristian Buchiu \u2013 \u0218ef adjunct al Reprezentan\u021bei Comisiei Europene \u00een Rom\u00e2nia<\/p>\n<p><span style=\"font-size: 18px; font-weight: normal;\" data-fusion-font=\"true\">Pe l\u00e2ng\u0103 func\u021bia de \u0218ef adjunct al Reprezentan\u021bei Comisiei Europene \u00een Rom\u00e2nia, Cristian Buchiu este \u0219i raportor politic \u0219i coordonator al sec\u021biei politice \u00een cadrul Departamentului Politic al Reprezentan\u021bei.<\/span><\/p><\/h3><\/div><div class=\"fusion-video fusion-youtube fusion-aligncenter\" style=\"--awb-max-width:800px;--awb-max-height:450px;--awb-width:100%;\"><div class=\"video-shortcode\"><div class=\"fluid-width-video-wrapper\" style=\"padding-top:56.25%;\" ><iframe class=\"lazyload\" title=\"YouTube video player 8\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27800%27%20height%3D%27450%27%20viewBox%3D%270%200%20800%20450%27%3E%3Crect%20width%3D%27800%27%20height%3D%27450%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.youtube.com\/embed\/mvcLlt9QPJM?wmode=transparent&autoplay=0\" width=\"800\" height=\"450\" allowfullscreen allow=\"autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture;\"><\/iframe><\/div><\/div><\/div><div class=\"fusion-text fusion-text-10\"><p>\u201eThe next critical steps: 2019, of course, it\u2019s just around the corner. Still many things remain to be done. In particular, it is now critical that the NMVO signs a contract with an appropriate IT provider, in order for the national database infrastructure to work and start. Last, but not least, the onboarding of verified users needs to be completed as soon as possible. (Users) need to be connected to the databases so that the system can be pilot tested in advance of the date in February 2019.<br \/>\nEverybody\u2019s efforts, industry, pharmacies, hospitals, competent authorities, are needed to make the safety features a success.\u201d<\/p>\n<\/div><div class=\"fusion-title title fusion-title-9 fusion-sep-none fusion-title-center fusion-title-text fusion-title-size-three\" style=\"--awb-margin-top-small:40px;--awb-margin-right-small:0px;--awb-margin-bottom-small:20px;--awb-margin-left-small:0px;\"><h3 class=\"fusion-title-heading title-heading-center fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:32;line-height:1.3;\">Ulrike Kreysa \u2013 Prim-Vicepresedinte GS1 Global<\/p>\n<p style=\"text-align: left;\"><span style=\"font-weight: normal; font-size: 18px;\" data-fusion-font=\"true\">Responsabil de domeniul S\u0103n\u0103tate Prim-Vicepre\u0219edinte al GS1 Global \u00eenc\u0103 din anul 2004, Ulrike Kreysa a fost Manager de Proiect al GHX, ulterior devenind Director Executiv al acestei companii.<\/span><\/p>\n<p style=\"text-align: left;\"><span style=\"color: var(--h3_typography-color); font-family: var(--h3_typography-font-family); font-size: var(--h3_typography-font-size); font-style: var(--h3_typography-font-style,normal); letter-spacing: var(--h3_typography-letter-spacing); background-color: rgba(255, 255, 255, 0); font-weight: normal;\"><span style=\"font-size: 18px;\" data-fusion-font=\"true\">GS1 este o organiza\u021bie global\u0103 dedicat\u0103 cre\u0103rii \u0219i implement\u0103rii unor standarde \u0219i solu\u021bii globale pentru \u00eembun\u0103t\u0103\u021birea eficien\u021bei \u0219i vizibilit\u0103\u021bii lan\u021bului de distribu\u021bie pe tot globul. Sistemul de standarde GS1 este cel mai r\u0103sp\u00e2ndit \u0219i folosit sistem standarde pentru lan\u021bul de distribu\u021bie la nivel global.<\/span><br \/>\n<\/span><span style=\"color: var(--h3_typography-color); font-family: var(--h3_typography-font-family); font-size: 18px; font-style: var(--h3_typography-font-style,normal); letter-spacing: var(--h3_typography-letter-spacing); background-color: rgba(255, 255, 255, 0); font-weight: normal;\" data-fusion-font=\"true\">Organiza\u021bia global\u0103 de standardizare a fost un partener strategic la nivel european pentru industrie \u0219i mediul de reglementare \u00een faza de preg\u0103tire a legisla\u021biei \u0219i este un partener strategic pentru faza de implementare, prin standardele privind identificatorii unici globali \u0219i simbologia DataMatrix ECC 200<\/span><\/p><\/h3><\/div><div class=\"fusion-video fusion-youtube fusion-aligncenter\" style=\"--awb-max-width:800px;--awb-max-height:450px;--awb-width:100%;\"><div class=\"video-shortcode\"><div class=\"fluid-width-video-wrapper\" style=\"padding-top:56.25%;\" ><iframe class=\"lazyload\" title=\"YouTube video player 9\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27800%27%20height%3D%27450%27%20viewBox%3D%270%200%20800%20450%27%3E%3Crect%20width%3D%27800%27%20height%3D%27450%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.youtube.com\/embed\/vAJBEwYgjS0?wmode=transparent&autoplay=0\" width=\"800\" height=\"450\" allowfullscreen allow=\"autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture;\"><\/iframe><\/div><\/div><\/div><div class=\"fusion-text fusion-text-11\"><p>\u201cNu pot s\u0103 subliniez c\u00e2t este de important ca \u021b\u0103rile s\u0103 avanseze; putem face 2019 un obiectiv realizabil cu \u021b\u0103ri care iau decizii la timp \u0219i \u00een care p\u0103r\u021bile interesate colaboreaz\u0103, dar dac\u0103 produc\u0103torii nu \u0219tiu \u00eenc\u0103 ce hot\u0103r\u00e2ri s-au luat \u00een \u021bara lor, este foarte greu pentru ei s\u0103 avanseze.\u201d<\/p>\n<\/div><div class=\"fusion-title title fusion-title-10 fusion-sep-none fusion-title-center fusion-title-text fusion-title-size-three\" style=\"--awb-margin-top-small:40px;--awb-margin-right-small:0px;--awb-margin-bottom-small:20px;--awb-margin-left-small:0px;\"><h3 class=\"fusion-title-heading title-heading-center fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:32;line-height:1.3;\">Valentin Popescu \u2013 Director Tehnic \u0219i Opera\u021biuni, OSMR<\/h3><\/div><div class=\"fusion-video fusion-youtube fusion-aligncenter\" style=\"--awb-max-width:800px;--awb-max-height:450px;--awb-width:100%;\"><div class=\"video-shortcode\"><div class=\"fluid-width-video-wrapper\" style=\"padding-top:56.25%;\" ><iframe class=\"lazyload\" title=\"YouTube video player 10\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27800%27%20height%3D%27450%27%20viewBox%3D%270%200%20800%20450%27%3E%3Crect%20width%3D%27800%27%20height%3D%27450%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.youtube.com\/embed\/GiGe9L36Ux0?wmode=transparent&autoplay=0\" width=\"800\" height=\"450\" allowfullscreen allow=\"autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture;\"><\/iframe><\/div><\/div><\/div><div class=\"fusion-text fusion-text-12\"><p>\u201eAutorit\u0103\u021bile din Rom\u00e2nia, Ministerul S\u0103n\u0103t\u0103\u021bii, ANMDM, Casa Na\u021bional\u0103 de Asigur\u0103ri de S\u0103n\u0103tate au r\u0103spuns primii, cu persoane \u00eemputernicite s\u0103 reprezinte institu\u021bia \u0219i opinia institu\u021biilor \u00een aceste Grupuri de Lucru. Aceasta este metoda agreat\u0103 \u0219i aprobat\u0103 de Consiliul Director al OSMR pentru a avea rezultate rapide, pentru a avea posibilitatea de a munci colaborativ \u0219i de a lua decizii prin consens cu privire la implementarea na\u021bional\u0103, dar, prin principiul de incluziune, orice entitate implicat\u0103, fiecare organiza\u021bie are acces asigurat c\u0103tre aceste Grupuri de Lucru.\u201d<\/p>\n<\/div><div class=\"fusion-video fusion-youtube fusion-aligncenter\" style=\"--awb-max-width:800px;--awb-max-height:450px;--awb-width:100%;\"><div class=\"video-shortcode\"><div class=\"fluid-width-video-wrapper\" style=\"padding-top:56.25%;\" ><iframe class=\"lazyload\" title=\"YouTube video player 11\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27800%27%20height%3D%27450%27%20viewBox%3D%270%200%20800%20450%27%3E%3Crect%20width%3D%27800%27%20height%3D%27450%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.youtube.com\/embed\/PwwDyESL_Qo?wmode=transparent&autoplay=0\" width=\"800\" height=\"450\" allowfullscreen allow=\"autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture;\"><\/iframe><\/div><\/div><\/div><div class=\"fusion-video fusion-youtube fusion-aligncenter\" style=\"--awb-max-width:800px;--awb-max-height:450px;--awb-width:100%;\"><div class=\"video-shortcode\"><div class=\"fluid-width-video-wrapper\" style=\"padding-top:56.25%;\" ><iframe class=\"lazyload\" title=\"YouTube video player 12\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27800%27%20height%3D%27450%27%20viewBox%3D%270%200%20800%20450%27%3E%3Crect%20width%3D%27800%27%20height%3D%27450%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.youtube.com\/embed\/HS0fzGlVRPM?wmode=transparent&autoplay=0\" width=\"800\" height=\"450\" allowfullscreen allow=\"autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture;\"><\/iframe><\/div><\/div><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":9,"featured_media":946,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34,24],"tags":[],"class_list":["post-1066","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-conferinte","category-stiri"],"translation":{"provider":"WPGlobus","version":"3.0.3","language":"en","enabled_languages":["ro","en"],"languages":{"ro":{"title":true,"content":true,"excerpt":false},"en":{"title":true,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/posts\/1066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/comments?post=1066"}],"version-history":[{"count":26,"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/posts\/1066\/revisions"}],"predecessor-version":[{"id":6116,"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/posts\/1066\/revisions\/6116"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/media\/946"}],"wp:attachment":[{"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/media?parent=1066"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/categories?post=1066"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/tags?post=1066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}